The University of Chicago Header Logo

Connection

David Barefield to Humans

Back to Details
This is a "connection" page, showing publications David Barefield has written about Humans.
David Barefield
Connection Strength
0.252
Humans
  1. Myosin-binding protein-H: Not just filler. J Gen Physiol. 2024 Dec 02; 156(12).
    View in: PubMed
    Score: 0.032
  2. Mechanisms of Sarcomere Protein Mutation-Induced Cardiomyopathies. Curr Cardiol Rep. 2023 06; 25(6):473-484.
    View in: PubMed
    Score: 0.029
  3. Is haploinsufficiency a sufficient mechanism for MYBPC3 truncating mutations? J Gen Physiol. 2023 04 03; 155(4).
    View in: PubMed
    Score: 0.029
  4. Partial and complete loss of myosin binding protein H-like cause cardiac conduction defects. J Mol Cell Cardiol. 2022 08; 169:28-40.
    View in: PubMed
    Score: 0.027
  5. Ablation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injury. J Mol Cell Cardiol. 2019 04; 129:236-246.
    View in: PubMed
    Score: 0.022
  6. It Takes a Village to Train a Scientist. Circ Res. 2017 09 29; 121(8):908-909.
    View in: PubMed
    Score: 0.019
  7. Experimental Modeling Supports a Role for MyBP-HL as a Novel Myofilament Component in Arrhythmia and Dilated Cardiomyopathy. Circulation. 2017 Oct 17; 136(16):1477-1491.
    View in: PubMed
    Score: 0.019
  8. Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice. J Mol Cell Cardiol. 2015 Feb; 79:234-43.
    View in: PubMed
    Score: 0.016
  9. Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J Mol Cell Cardiol. 2010 May; 48(5):866-75.
    View in: PubMed
    Score: 0.011
  10. Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias. J Am Heart Assoc. 2024 May 21; 13(10):e030467.
    View in: PubMed
    Score: 0.008
  11. Anti-latent TGFß binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy. Sci Transl Med. 2021 Sep 08; 13(610):eabf0376.
    View in: PubMed
    Score: 0.006
  12. Altered Enhancer and Promoter Usage Leads to Differential Gene Expression in the Normal and Failed Human Heart. Circ Heart Fail. 2020 10; 13(10):e006926.
    View in: PubMed
    Score: 0.006
  13. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes. JCI Insight. 2019 03 21; 4(6).
    View in: PubMed
    Score: 0.005
  14. Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping. J Clin Invest. 2015 Nov 02; 125(11):4186-95.
    View in: PubMed
    Score: 0.004
  15. Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation. Oxid Med Cell Longev. 2015; 2015:424751.
    View in: PubMed
    Score: 0.004
  16. The genetic landscape of cardiomyopathy and its role in heart failure. Cell Metab. 2015 Feb 03; 21(2):174-182.
    View in: PubMed
    Score: 0.004
  17. A sensitive and specific quantitation method for determination of serum cardiac myosin binding protein-C by electrochemiluminescence immunoassay. J Vis Exp. 2013 Aug 08; (78).
    View in: PubMed
    Score: 0.004
  18. Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol. 2012 Jan; 52(1):154-64.
    View in: PubMed
    Score: 0.003
  19. A critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac function. Circ Res. 2011 Jul 08; 109(2):141-50.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.